Matrix heparan sulphate, but not endothelial cell surface heparan sulphate, is degraded by highly metastatic mouse lymphoma cells
1988

Degradation of Heparan Sulphate by Mouse Lymphoma Cells

publication Evidence: moderate

Author Information

Author(s): R. Hennes, F. Frantzen, R. Keller, V. Schirrmacher, R. Schwartz-Albiez

Primary Institution: Aachen Technical University and German Cancer Research Center

Hypothesis

The production of an ECM-proteoheparan sulphate-specific endoglycosidase is a pivotal factor for the invasive capacity of a tumour cell.

Conclusion

The study confirms that highly metastatic lymphoma cells can degrade specific proteoglycans, which may facilitate their invasion through blood vessel walls.

Supporting Evidence

  • Highly metastatic lymphoma cells showed endoglycosidase activity that was absent in low-metastatic cells.
  • Degradation of specific proteoglycans was observed only with the highly metastatic variant of the lymphoma.
  • Proteolytic activity may enhance the accessibility of proteoglycans for endoglycosidase action.

Takeaway

Some cancer cells can break down certain substances in the body that help them spread, which might help them invade other areas.

Methodology

The study involved incubating different lymphoma cell lines with proteoglycan-coated plates to observe degradation activity.

Limitations

The study does not address the effects of other potential factors influencing tumor cell invasion.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication